[Acute rejection of pancreatic grafts].
A
A
Guitián Pena
A
A
Alonso Hernández
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D000961:Antilymphocyte Serum; D065095:Calcineurin Inhibitors; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D006084:Graft Rejection / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006973:Hypertension / Q000150:complications; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000276:immunology*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; C512542:thymoglobulin; D016559:Tacrolimus; D008775:Methylprednisolone